Related Experiment Videos

Identification of a colon mucosa gene that is down-regulated in colon adenomas and adenocarcinomas

C W Schweinfest1, K W Henderson, S Suster

  • 1Laboratory of Molecular Oncology, National Cancer Institute, Frederick, MD 21702-1201.

Insights

A novel gene, DRA (down-regulated in adenoma), is highly expressed in normal colon tissue but significantly decreased in colon tumors. This suggests DRA may function as a tumor suppressor in colorectal cancer.

Area of Science:

  • Molecular biology
  • Genetics
  • Cancer research

Background:

  • The DRA (down-regulated in adenoma) gene's expression pattern in normal and cancerous colon tissue is largely unknown.
  • Understanding genes involved in colorectal tumorigenesis is crucial for developing new diagnostic and therapeutic strategies.

Purpose of the Study:

  • To isolate and characterize the DRA gene.
  • To investigate the expression levels of DRA in normal colon tissue, adenomas, and adenocarcinomas.
  • To predict the function of the DRA protein and its potential role in colorectal cancer.

Main Methods:

  • cDNA isolation and characterization.
  • mRNA expression analysis using Northern blotting or similar techniques.
  • Bioinformatic analysis of the predicted protein sequence and chromosomal location.

Main Results:

  • Isolation of the DRA cDNA, with mRNA exclusively expressed in normal colon mucosal epithelia.
  • Significantly decreased DRA gene expression observed in colon adenomas and adenocarcinomas.
  • DRA gene located on chromosome 7, a region implicated in colorectal cancer.
  • Predicted DRA polypeptide (84.5 kDa) possesses features of a transcription factor, including nuclear targeting motifs and a homeobox domain.

Conclusions:

  • The DRA gene is down-regulated during colorectal tumorigenesis.
  • The predicted function of the DRA protein suggests a role in tissue-specific gene regulation.
  • DRA is a candidate tumor-suppressor gene in the colon.

Related Concept Videos